Profil
Peter Halling is currently President & Chief Executive Officer at ALK-Abello A since 2024.
Mr. Halling is also Chief Financial Officer at Fertin Pharma A since 2020.
Mr. Halling graduated from Copenhagen Business School.
Postes actifs de Peter Halling
| Sociétés | Poste | Début |
|---|---|---|
| ALK-ABELLÓ A/S | Directeur Général | 01/01/2024 |
Fertin Pharma A/S
Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Develops and manufactures medical chewing gum products | Directeur Financier/CFO | - |
Formation de Peter Halling
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
ALK-Abello A/S
ALK-Abello A/S Pharmaceuticals: MajorHealth Technology Develops and produces, markets products for diagnosing, treating allergies, allergic asthma & acute anaphylactic reactions | Health Technology |
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fertin Pharma A/S
Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Develops and manufactures medical chewing gum products | Consumer Non-Durables |
















